Camphorquinone Derivative Having Acylphosphine Oxide Group, Photopolymerization Catalyst And Photo/Chemical Polymerization Catalyst Containing The Same And Hardenable Composition Contaning The Same
    1.
    发明申请
    Camphorquinone Derivative Having Acylphosphine Oxide Group, Photopolymerization Catalyst And Photo/Chemical Polymerization Catalyst Containing The Same And Hardenable Composition Contaning The Same 有权
    具有酰基氧化膦基团的樟脑醌衍生物,光聚合催化剂和含有相同和可固化组合物的光化学聚合催化剂

    公开(公告)号:US20090105361A1

    公开(公告)日:2009-04-23

    申请号:US12225070

    申请日:2006-03-13

    Abstract: A compound that exhibits excellent color tone stability and physical properties as well as excellent photopolymerization activity over a wide region from near-ultraviolet to visible region, permitting relaxed operation under ambient light, so that wide application can be found in the dental field and photopolymerization industry; and a relevant photopolymerization initiator and hardenable composition. In particular, there is provided a novel camphorquinone derivative having an acylphosphine oxide group [—(C═O)—(P═O)

    Abstract translation: 具有优异的色调稳定性和物理性能以及在从近紫外到可见光区域的广泛区域的优异的光聚合活性的化合物,允许在环境光下轻松操作,从而可以在牙科领域和光聚合行业中广泛应用 ; 和相关的光聚合引发剂和可硬化组合物。 特别地,提供了在每个分子中具有酰基氧化膦基团[ - (C-O) - (P-O)]]的新型樟脑醌衍生物。 此外,提供了包含在每个分子中具有丙烯基氧化膦基团[ - (CO) - (PO)]]的樟脑醌衍生物作为不可或缺的组分的光聚合引发剂,其负载有至少一种选自聚合促进剂, 光致酸产生剂,光敏剂和(双)酰基氧化膦,并提供包含引发剂的可硬化组合物。 由此提供的光聚合引发剂和可硬化组合物在紫外线和可见光波长范围内表现出优异的色调稳定性和物理性能以及优异的光聚合活度,允许在环境光下轻松操作,从而可以在牙科领域和 光聚合行业。

    Acyl-(2'-hydroxybiphenyl-2-yl)-phosphinic acid salts, their preparation
and use
    4.
    发明授权
    Acyl-(2'-hydroxybiphenyl-2-yl)-phosphinic acid salts, their preparation and use 失效
    酰基 - (2'-羟基联苯-2-基) - 次膦酸盐,其制备和用途

    公开(公告)号:US5407969A

    公开(公告)日:1995-04-18

    申请号:US50347

    申请日:1993-04-16

    CPC classification number: C07F9/307 C08F2/50 C08K5/5313 G03F7/029

    Abstract: The invention relates to acyl-(2'-hydroxydiphenyl-2-yl)-phosphinic acid salts of formula (I) ##STR1## in which each of the radicals R.sup.1, R.sup.2 and R.sup.3 may be included singly or multiply and in which R.sup.1 and R.sup.2 are mutually independently hydrogen, an alkyl or alkoxy radical with 1 to 6 carbon atoms or halogen with an atomic number of 9 to 35; R.sup.3 means the same as R.sup.1 or R.sup.2 ; Ar is an aromatic hydrocarbon radical with 6 to 10 carbon atoms; and Me is a cation of at least one alkaline metal or N(R.sup.4).sub.4 + in which the radicals R.sup.4 are the same or different and stand for an alkyl radical with 1 to 6 carbon atoms. The invention also relates to a process for producing these compounds (I) and their use as photoinitiators in photopolymerisable materials, preferably on an aqueous basis.

    Abstract translation: PCT No.PCT / EP91 / 01919 Sec。 371日期:1993年04月16日 102(e)日期1993年4月16日PCT 1991年10月9日PCT公布。 出版物WO92 / 06983 本发明涉及式(I)的酰基 - (2'-羟基二苯基-2-基) - 次膦酸盐R2和R3可以单独或多次包括,其中R 1和R 2相互独立地 氢,具有1至6个碳原子的烷基或烷氧基或原子序数为9至35的卤素; R3表示与R1或R2相同; Ar是具有6-10个碳原子的芳族烃基; 和Me是至少一种碱金属或N(R 4)4+的阳离子,其中基团R 4相同或不同,代表具有1至6个碳原子的烷基。 本发明还涉及一种制备这些化合物(I)的方法及其在可光聚合材料中的光引发剂的用途,优选在水性基础上。

    Process of making isoprenoid phosphinylformic acid squalene synthetase
inhibitors
    5.
    发明授权
    Process of making isoprenoid phosphinylformic acid squalene synthetase inhibitors 失效
    制备类异戊二烯基膦酰基甲酸角鲨烯合成酶抑制剂的方法

    公开(公告)号:US5166386A

    公开(公告)日:1992-11-24

    申请号:US811130

    申请日:1991-12-20

    Inventor: Scott A. Biller

    CPC classification number: C07F9/3886 C07F9/307 C07F9/3252 C07F9/4062

    Abstract: Compounds which are inhibitors of cholesterol biosynthesis (by inhibiting de novo squalene biosynthesis), and thus are useful as hypocholesterolemic agents and antiatherosclerotic agents, are provided which have the structure ##STR1## wherein R.sup.2 is a metal ion, lower alkyl or H;R.sup.3 is a metal ion or lower alkyl;R is R.sup.1 --(CH.sub.2).sub.n --, R.sup.1 --(CH.sub.2).sub.m --O-- orR.sup.1 --(CH.sub.2).sub.m --OCH.sub.2 --, wherein n is 1 to 4 and m is 0 to 3, andR.sup.1 is R.sup.5 --Q.sup.1 --Q.sup.2 --Q.sup.3 --wherein R.sup.5, Q.sup.1, Q.sup.2 and Q.sup.3 are as defined herein.New intermediates, new methods of preparation and a method for using such compounds to inhibit cholesterol biosynthesis are also provided.

    Abstract translation: 作为胆固醇生物合成抑制剂的化合物(通过抑制从头角鲨烯生物合成),因此可用作具有下列结构的降胆固醇血症药和抗动脉粥样硬化剂:其中R2是金属离子,低级烷基或H; R3是金属离子或低级烷基; R为(R 1 - (CH 2)n + 13,R 1 - (CH 2)m O-或R 1 - (CH 2)m -OCH 2 - ,其中n为1至4,m为0至3,R1为R5-Q1-Q2 -Q3-其中R5,Q1,Q2和Q3如本文所定义。 还提供了新的中间体,新的制备方法和使用这些化合物抑制胆固醇生物合成的方法。

    DERIVATIVES OF BISACYLPHOSPHINIC ACID, THEIR PREPARATION AND USE AS PHOTOINITIATORS
    6.
    发明申请
    DERIVATIVES OF BISACYLPHOSPHINIC ACID, THEIR PREPARATION AND USE AS PHOTOINITIATORS 审中-公开
    双磷酸的衍生物,其制备和用作光敏剂

    公开(公告)号:US20160039851A1

    公开(公告)日:2016-02-11

    申请号:US14653579

    申请日:2013-12-16

    Applicant: BASF SE

    Abstract: Bisacylphosphine oxide or bisacylphosphine sulfide compounds of formula (I) or (II) wherein R1, R2, R3, R1a, R2a and R3a independently of each other are C1-C4alkoxy or halogen; X is O, NR5 or S; or, if R4 is Cl, F or Br, X is a direct bond; Y is O or S; n is 1 or 2; R4, if n is 1, for example is hydrogen, (CO)R6, (CO)OR6, (CO)NR5R6, (SO2)—R6, C1-C28alkyl, R4, if n=2, is for example C1-C18alkylene; R5 is for example hydrogen, or C1-C12alkyl; R6 is for example C1-C12alkyl; R7, R8 and R9 independently of each other for example are C1-C4alkyl; R10 is for example C2-C18alkylene; X, is O or S; m is 1, 2 or 3; Q represents one or two inorganic or organic cations with a charge of m+; are suitable photoinitiators, available by a claimed process.

    Abstract translation: 式(I)或(II)的双酰基氧化膦或双酰基膦硫化物,其中R1,R2,R3,R1a,R2a和R3a彼此独立地为C1-C4烷氧基或卤素; X为O,NR5或S; 或者如果R4是Cl,F或Br,则X是直接键; Y为O或S; n为1或2; R4如果n为1,例如是氢,(CO)R6,(CO)OR6,(CO)NR5R6,(SO2)-R6,C1-C228烷基,R4如果n = 2,则为例如C 1 -C 18亚烷基 ; R5是例如氢或C1-C12烷基; R6是例如C1-C12烷基; R 7,R 8和R 9彼此独立地为C 1 -C 4烷基; R10例如为C 2 -C 18亚烷基; X,是O或S; m为1,2或3; Q表示一种或两种带电荷的无机或有机阳离子; 是合适的光引发剂,可由所要求保护的方法获得。

Patent Agency Ranking